Literature DB >> 12629155

Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages.

James J Kohler1, Daniel L Tuttle, Carter R Coberley, John W Sleasman, Maureen M Goodenow.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) impacts the activation state of multiple lineages of hematopoietic cells. Chronic HIV-1 infection among individuals with progressive disease can be associated with increased levels of activated signal transducers and activators of transcription (STATs) in peripheral blood mononuclear cells. To investigate interactions between HIV-1 and CD4(+) cells, activated, phosphorylated STAT proteins in nuclear extracts from lymphocytic and promonocytic cell lines as well as primary monocyte-derived macrophages were measured. Levels of activated STATs increased six- to tenfold in HUT78 and U937 cells within 2 h following exposure to virions. The response to virus was dose-dependent, but kinetics of activation was delayed relative to interleukin-2 or interferon-gamma. Activation of STAT1, STAT3, and STAT5 occurred with diverse viral envelope proteins, independent of coreceptor use or viral replication. Envelope-deficient virions had no effect on STAT activation. Monoclonal antibody engagement of CD4 identified a novel role for CD4 as a mediator in the activation of multiple STATs. Results provide a model for HIV-1 pathogenesis in infected and noninfected hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629155     DOI: 10.1189/jlb.0702358

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  28 in total

1.  Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets.

Authors:  Theodore J Cory; Hui He; Lee C Winchester; Santosh Kumar; Courtney V Fletcher
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

2.  HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication.

Authors:  K Sofia Appelberg; Mark A Wallet; Jared P Taylor; Melanie N Cash; John W Sleasman; Maureen M Goodenow
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-12       Impact factor: 2.205

3.  Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses.

Authors:  Richard J Connolly; Taryn Chapman; Andrew M Hoff; Michele A Kutzler; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

4.  Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages.

Authors:  Joseph Brown; Mark A Wallet; Bryan Krastins; David Sarracino; Maureen M Goodenow
Journal:  J Leukoc Biol       Date:  2010-04       Impact factor: 4.962

5.  Human Immunodeficiency Virus Related Myelofibrosis Responsive to Low Dose Thalidomide.

Authors:  Sunita Sharma; Jagdish Chandra; Rohini Gupta; Richa Chauhan
Journal:  Indian J Pediatr       Date:  2016-05-11       Impact factor: 1.967

6.  Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro.

Authors:  Christina Gavegnano; Mervi Detorio; Catherine Montero; Alberto Bosque; Vicente Planelles; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

7.  Host and virus strain dependence in activation of human macrophages by human immunodeficiency virus type 1.

Authors:  Katarzyna Kazmierczak; Mary Jane Potash
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

8.  Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages.

Authors:  Laura Fantuzzi; Francesca Spadaro; Cristina Purificato; Serena Cecchetti; Franca Podo; Filippo Belardelli; Sandra Gessani; Carlo Ramoni
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

9.  HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.

Authors:  Brian Giunta; Yuyan Zhou; Huayan Hou; Elona Rrapo; Francisco Fernandez; Jun Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 10.  The utilization of humanized mouse models for the study of human retroviral infections.

Authors:  Rachel Van Duyne; Caitlin Pedati; Irene Guendel; Lawrence Carpio; Kylene Kehn-Hall; Mohammed Saifuddin; Fatah Kashanchi
Journal:  Retrovirology       Date:  2009-08-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.